NephJC is a nephrology journal club that uses Twitter to discuss the research, guidelines, and editorials that drive nephrology.
Atrosentan makes a return visit to NephJC, but now it goes beyond changes in proteinuria and shows improved kidney outcomes. Is it enough to overcome the fluid complications?
This week, we will discuss a risk score which helps to prognosticate the most common glomerular disease. Not only is IgA most common - it is quite heterogeneous, which makes the problem of who should get treated quite difficult.
Upcoming Twitter chats:
All scheduled chats are tentative. We may change the schedule depending on the whims of the NephJC work group
June 11, 12 NephJC: Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial (SONAR)
June 18 #AskASN Kidney Health Initiative with new co-chair Dr. Ray Harris
July 30 #AskASN Fellow Talk
August 6, 7 NephJC: Reconsidering the Consequences of Using Race to Estimate Kidney Function
August #AskASN: Why you must go to Kidney Week
August 20,21: Calciphylaxis with DermJC: Image-Guided Core-Needle Biopsy for the Diagnosis of Cutaneous Calciphylaxis
September #AskASN: Renal Educator’s Community
The NephJC Book Club
Every summer we blog our way through a book of medical interest and have a Twitter-based book club discussion. Join us July 23rd and 24th to discuss Doctor by Andrew Bomback.
2019 Andrew Bomback’s Doctor (Object Lessons)
2018 Siddhartha Mukherjee's Laws of Medicine, Field Notes from an Uncertain Science
2017 Vanessa Grubb's, Hundreds of Interlaced Fingers.
2016 Eric Topol's, The Patient Will See You Now
2015 Atul Gawande's, Being Mortal
Twice a month, the filtrate (Jenie Lin, Joel Topf, Samira Farouk, Matt Sparks, and Swapnil Hiremath) sit down and recap the latest NephJC discussion. We go as deep as it takes. Give it a listen.
The NephJC Twitter Journal Club Primer
The NephJC work group has produced a primer to document some of our thoughts on the practices on running a Twitter Journal Club. We think it is quite good. Take a look.
In the last year, NephJC has injected some statistical muscle into its editorial team (thank you Perry Wilson and Laurie Tomlinson). Then Manasi Bapat volunteered to create some cogent explainers for the various techniques that are routinely described in the methods section most of us skip over as we rush to the results. Here are the recent posts...
She’s back: A stats explainer of statistical modelling, goodness of fit and the Bayes information criterion from Manasi Bapat.
When a study is negative the work is not done. Time to separate a negative trial from an underpowered one. Learn how to think about this with Manasi Bapat.
Propensity scores…what’s up with that?
Multiple testing and the Bonferroni - NSMC intern and NephJC stats explainer Manasi Bapat breaks it down for you in this post.
Manasi deconstructs pragmatic trials for us. How are they different compared to efficacy & explanatory trials?
Manasi Bapat takes you behind the scenes to explain the need for doing sensitivity analyses
We begin a series of occasional commentary on the methods underlying the research being discussed. This edition: the 2 x 2 factorial designs.
The visual abstract for SONAR
The winners of the third annual NephJC Kidneys
Thanks for voting. On Oct 26th at the #KidneyWk Beach Party we announced the winners in all 5 categories.
Rookie of the Year: Mohamed Elrggal
Most Engaged Scientist: Marvin Gonzalez
Study of the Year: A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops
Most Valuable Player: Maryam Khosravi
Nathan Hellman Social Media Project of the Year: The GlomCon Interactive Fellows’ Curriculum
See some great pictures from the event here.